MedCap AB (publ)
MCAP.ST - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.71B
Close$
$1289.96
133.3% upside
Current Fair Value
133.3% upsideUndervalued by 133.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.71 Billion |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $14.67 |
| Beta | 0.47 |
| Outstanding Shares | 14,973,633 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 32.11 |
|---|---|
| PEG | 111.03 |
| Price to Sales | 3.69 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
October 23, 2026
EPS Estimate
$4.57
Consensus analyst estimateRevenue Estimate
$567.75 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 5, 2027
EPS Estimate
$5.66
Consensus analyst estimateRevenue Estimate
$648.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MedCap AB (publ)
647 employees
CEO: Anders Dahlberg
MedCap AB (publ) operates as a private equity firm, employing a diverse array of investment strategies including secondary direct deals, later-stage funding, industry consolidation, growth capital provision, engagement with middle-market...